摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Octadec-11-en-1-ol

中文名称
——
中文别名
——
英文名称
Octadec-11-en-1-ol
英文别名
——
Octadec-11-en-1-ol化学式
CAS
——
化学式
C18H36O
mdl
——
分子量
268.5
InChiKey
XMLQWXUVTXCDDL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.4
  • 重原子数:
    19
  • 可旋转键数:
    15
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS
    申请人:PROVIVI, INC.
    公开号:US20170137365A1
    公开(公告)日:2017-05-18
    In one aspect, the invention provides a method for synthesizing a fatty olefin derivative. The method includes: a) contacting an olefin according to Formula I with a metathesis reaction partner according to Formula IIb in the presence of a metathesis catalyst under conditions sufficient to form a metathesis product according to Formula IIIb: and b) converting the metathesis product to the fatty olefin derivative. Each R 1 is independently selected from H, C 1-18 alkyl, and C 2-18 alkenyl; R 2b is C 1-8 alkyl; subscript y is an integer ranging from 0 to 17; and subscript z is an integer ranging from 0 to 17. In certain embodiments, the metathesis catalyst is a tungsten catalyst or a molybdenum catalyst. In various embodiments, the fatty olefin derivative is a pheromone. Pheromone compositions and methods of using them are also described.
    在一个方面,该发明提供了一种合成脂肪烯衍生物的方法。该方法包括:a)在存在一种烯烃催化剂的条件下,将符合式I的烯烃与符合式IIb的交换反应伙伴接触,以形成符合式IIIb的交换产物;并b)将交换产物转化为脂肪烯衍生物。每个R1独立地选择自H、C1-18烷基和C2-18烯基;R2为C1-8烷基;下标y为0至17之间的整数;下标z为0至17之间的整数。在某些实施方式中,交换催化剂为钨催化剂或钼催化剂。在各种实施方式中,脂肪烯衍生物为信息素。还描述了信息素组合物及其使用方法。
  • Method for Producing Aldehyde and Ketone
    申请人:Yamashita Miyoshi
    公开号:US20110282102A1
    公开(公告)日:2011-11-17
    Provided is a highly efficient method for the production of aldehydes and ketones, which is inexpensive, exhibits high reactivity, and is capable of easy separation of byproduct after the reaction. More particularly, there is provided a method for producing an aldehyde or a ketone, comprising at least an oxidation step of oxidizing a primary alcohol or a secondary alcohol in the presence of a polymeric carbodiimide represented by the following formula (1) and having a weight-average molecular weight of 300 to 5000, and a sulfoxide compound, together with an acid and a base, or together with a salt of the acid and the base.
    提供了一种高效的生产醛和酮的方法,该方法廉价、具有高反应性,并能够在反应后轻松分离副产物。更具体地,提供了一种生产醛或酮的方法,包括至少一个氧化步骤,即在聚合物碳二亚胺(表示为以下式(1)且具有分子量为300至5000的重均分子量)和亚砜化合物的存在下氧化一级醇或二级醇,以及酸和碱,或者酸和碱的盐。
  • AGRICULTURAL PHEROMONE COMPOSITIONS COMPRISING POSITIONAL ISOMERS
    申请人:PROVIVI, INC.
    公开号:US20170135343A1
    公开(公告)日:2017-05-18
    The present disclosure provides pheromone compositions. In some aspects, the compositions taught herein comprise a pheromone chemically corresponding to the pheromone naturally produced by a given insect, along with at least one positional isomer of said pheromone. In various aspects, pheromone compositions of the present disclosure are able to modulate the response of the insect based on the ratio of natural pheromone to its positional isomer.
    本公开提供信息素组合物。在某些方面,本文所教授的组合物包括一种与某种昆虫自然产生的信息素在化学上相对应的信息素,以及至少一种该信息素的位置异构体。在各个方面,本公开的信息素组合物能够通过自然信息素与其位置异构体的比例来调节昆虫的反应。
  • 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity
    申请人:Hodson Harold Francis
    公开号:US20080161301A1
    公开(公告)日:2008-07-03
    The use of a compound comprising formula (I): or a salt, ester, amide or prodrug thereof in the inhibition of an enzyme whose preferred mode of action is to catalyse the hydrolysis of an ester functionality, e.g. in the control and inhibition of unwanted enzymes in products and processes. The compounds are also useful in medicine e.g. in the treatment of obesity and related conditions. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them. In formula (I) A is a 6-membered aromatic or heteroaromatic ring; and R 1 is a branched or unbranched alkyl (optionally interrupted by one or more oxygen atoms), alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl or a substituted derivative of any of the foregoing groups.
    使用式(I)的化合物或其盐、酯、酰胺或前药在抑制一种首选模式为催化酯官能团水解的酶方面具有应用,例如在产品和过程中控制和抑制不需要的酶。该化合物也在医学上有用,例如在肥胖和相关疾病的治疗中。该发明还涉及式(I)内的新化合物,以及制备它们的过程和含有它们的药物组成物。 在式(I)中,A是6元芳香或杂芳香环;而R1是支链或非支链烷基(可选地被一个或多个氧原子打断)、烯基、炔基、环烷基、环烯基、芳基、芳基烷基、还原芳基烷基、芳基烯基、杂芳基、杂芳基烷基、杂芳基烯基、还原芳基、还原杂芳基、还原杂芳基烷基或上述任何基团的取代衍生物。
  • 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF OBESITY
    申请人:Hodson Harold Francis
    公开号:US20110065697A1
    公开(公告)日:2011-03-17
    The use of a compound comprising formula (I): or a salt, ester, amide or prodrug thereof in the inhibition of an enzyme whose preferred mode of action is to catalyse the hydrolysis of an ester functionality, e.g. in the control and inhibition of unwanted enzymes in products and processes. The compounds are also useful in medicine e.g. in the treatment of obesity and related conditions. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them. In formula (I) A is a 6-membered aromatic or heteroaromatic ring; and R 1 is a branched or unbranched alkyl (optionally interrupted by one or more oxygen atoms), alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl or a substituted derivative of any of the foregoing groups.
    使用公式(I)的化合物或其盐,酯,酰胺或前药在抑制其首选作用方式为催化酯官能团水解的酶中的应用,例如在产品和过程中控制和抑制不需要的酶。该化合物在医学上也很有用,例如在肥胖和相关疾病的治疗中。该发明还涉及公式(I)内的新化合物、制备它们的过程以及含有它们的制药组合物。在公式(I)中,A是6元芳香或杂芳香环;R1是支链或直链烷基(可选地由一个或多个氧原子中断),烯基,炔基,环烷基,环烯基,芳基,芳基烷基,还原芳基烷基,芳基烯基,杂芳基,杂芳基烷基,杂芳基烯基,还原芳基,还原杂芳基,还原杂芳基烷基或任何上述基团的取代衍生物。
查看更多